The BCMA/CD19 Dual Targeted CAR-T Cell in Participants With Autoimmune Kidney Diseases

NCT06285279 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

24

Enrollment

OTHER

Sponsor class

Conditions

Lupus Nephritis
ANCA-associated Vasculitis
Membranous Nephropathy - PLA2R Induced
IgG4-Related Diseases

Interventions

DRUG: FKC288

Sponsor

Nanjing University School of Medicine